WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lucid Diagnostics earnings were -$52.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest LUCD earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$12.4M, up 12.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LUCD reported annual earnings of -$52.7M, with -6.2% growth.

LUCD earnings history

Current Revenue
$4.2M
Current Earnings
-$52.3M
Current Profit Margin
-1,248.8%

LUCD Return on Equity

Current Company
-656%
Current Industry
11.4%
Current Market
35.9%
LUCD's Return on Equity (-656%)... subscribe to Premium to read more.
High Return on Equity Performance

LUCD Return on Assets

Current Company
-180.3%
Current Industry
6.6%
LUCD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LUCD announces earnings.

LUCD Return on Capital Employed

Current Company
-536.45%
Current Industry
8.8%
LUCD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LUCD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LUCD-$43.21M-$52.31MN/A-$1.13
CTSO-$16.55M-$18.67MN/A-$0.36
NVNO-$20.70M-$21.24MN/A-$1.29
NXL-$5.52M-$5.55MN/A-$0.64
APYX-$22.10M-$28.44MN/A-$0.83
View Top Medical Device Stocks

Lucid Diagnostics Earnings Reports & History FAQ

What were Lucid Diagnostics's earnings last quarter?

On LUCD's earnings call on Invalid Date, Lucid Diagnostics (NASDAQ: LUCD) reported Q3 2024 earnings per share (EPS) of -$0.25, up 26.47% year over year. Total LUCD earnings for the quarter were -$12.37 million. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.34.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.

Is Lucid Diagnostics profitable or losing money?

As of the last Lucid Diagnostics earnings report, Lucid Diagnostics is currently losing money. Lucid Diagnostics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$44.82 million, a 21.05% decrease year over year.

What was LUCD's earnings growth in the past year?

As of Lucid Diagnostics's earnings date in Invalid Date, Lucid Diagnostics's earnings has grown year over year. LUCD earnings in the past year totalled -$52.31 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.